Nektar Therapeutics (NKTR) Q4 2020 Earnings Call Transcript

Motley Fool Transcribers, The Motley Fool
·53-min read
Nektar Therapeutics (NKTR) Q4 2020 Earnings Call Transcript

Ladies and gentlemen, thank you for standing by, and welcome to the Nektar Therapeutics Fourth Quarter 2020 Financial Results. With us on the call are Howard Robin, our President and CEO; Gil Labrucherie, our COO and CFO; Dr. Jonathan Zalevsky, our Chief of Research and Development; and Dr. Brian Kotzin, our Interim Chief Medical Officer and Head of Development.